A systematic review of oxygen and airflow effect on relief of dyspnea at rest in patients with advanced disease of any cause

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 18, Issue 4, 2004, Pages 3-15

  Gallagher, Romayne ^a,c   Roberts, Della ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b FRASER HEALTH AUTHORITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Advanced disease; Dyspnea; Oxygen; Palliative care; Systematic review

Indexed keywords

MORPHINE; OPIATE; PLACEBO;

ADULT; CANNULATION; CONTROLLED STUDY; DYSPNEA; FEMALE; HIGH RISK PATIENT; HUMAN; HYPOXEMIA; HYPOXIA; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; OXYGEN TRANSPORT; PALLIATIVE THERAPY; PATIENT CARE; PULSE OXIMETRY; RESPIRATORY AIRFLOW; RESPIRATORY FUNCTION; REST; REVIEW; RISK BENEFIT ANALYSIS; SURVIVAL; SYSTEMATIC REVIEW; TERMINAL DISEASE; VISUAL ANALOG SCALE;

AGED; COMORBIDITY; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS; REST; TREATMENT OUTCOME;

EID: 15244339924     PISSN: 15360288     EISSN: None     Source Type: Journal    
DOI: 10.1300/J354v18n04_02     Document Type: Review

References (23)

1. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease: A clinical trial. Ann Intern Med. 1980; 93: 391-8.
2. Dudgeon D, Lertzman M, Askew G. Physiological changes and clinical correlations of dyspnea in cancer outpatients. J Pain Symptom Manage. 2001; 21(5): 373-9.
3. British Columbia Ministry. of Health and Ministry Responsible for Seniors. Guidelines and Medical Indications for Home Oxygen Therapy, February 1998.
4. Heyse-Moore L, Beynon T, Ross V. Does spirometry predict dyspnea in advanced cancer? Palliat Med. 2000; 14: 189-95.
5. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14: 377-81.
6. Mahler DA. The measurement of dyspnea during exercise in patients with lung disease. Chest. 1992 May; 101(5 Suppl): 242S-247S.
7. Oxford Centre for Evidence-Based Medicine 2001. URL: http:/www.cebm.net/ levels_of_evidence.asp
8. Bruera E, Schoeller T, MacEachern T. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: The use N of 1 randomized controlled trial. J Pain Symptom Manage. 1992 Aug; 7 (6): 365-8.
9. Bruera E, de Stoutz N, Velasco-Leiva A, Schoeller T, Hanson J. Effects of oxygen on dyspnea in hypoxaemic terminal-cancer patients. Lancet 1993; 342: 13-4.
10. Booth S, Kelly M, Cox N, Adams L, Guz A. Am J Respir Crit Care Med. 1996; 153: 1515-8.
11. Swinburn C, Mould H, Stone T, Corris P, Gibson GJ. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. Am Rev Respir Dis. 1991; 143: 913-15.
12. Liss HP, Grant BJB. The effect of nasal flow on breathlessness in pts with COPD. Am Rev Respir Dis. 1988; 137 (6): 1285-8.
13. Nekolaichuk CL, Maguire TO, Suarez-Almazor M, Rogers WT, Bruera E. Assessing the reliability of patient, nurse, and family caregiver symptom ratings in hospitalized advanced cancer patients. J Clin Oncol. 1999; 17 (11): 3621-30.
14. Bruera E, Sweeney C, Willey J, Palmer JL, Strasser F, Morice RC, Pisters K. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliat Med. 2003; 17: 659-63.
15. Bruera E, MacEachern T, Ripamonti C, Hanson J. Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med. 1993; 119: 906-7.
16. Poole PJ, Veale AG, Black PN. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157 (6 Pt 1): 1877-80.
17. Allard P, Lamontagne C, Bernard P, Tremblay C. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. J Pain Symptom Manage. 1999; 17: 256-65.
18. Jennings AL, Davies A, Higgins JPT, Broadley K. Opioids for the palliation of breathlessness in terminal illness (Cochrane Review). In: The Cochrane Library, Issue 4, 2001. Oxford: Update Software.
19. Booth S, Wade R. Oxygen or air for palliative of breathlessness in advanced cancer. J R Soc Med. 2003; 96: 215-8.
20. Booth S, Anderson H, Swannick M, Wade R, Kite S, Johnson M. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the scientific committee of the association of palliative medicine. Resp Med. 2004; 98: 66-77.
21. Patel A, Jaeschke R, Guyatt GH, Keller JL, Newhouse MT. Clinical Usefulness of n-of-1 randomized controlled trials in patients with nonreversible chronic airflow limitation. Am Rev Respir Dis. 1991; 144 (4): 962-4.
22. Nikles CJ, Glasziou PP, Del Mar CB, Duggan CM, Mitchell G. N of 1 trials. Practical tools for medication management. Aust Fam Physician. 2000; 29 (11): 1108-12.
23. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Chuong B. Randomized, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003; 327: 523-8.